Lotus Pharmaceutical Co Ltd
TWSE:1795
Lotus Pharmaceutical Co Ltd
TWSE:1795
Price:
216
TWD
0.93%
Market Closed
Market Cap:
NT$57.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
TW |
|
S
|
Star Group LP
NYSE:SGU
|
US |
|
F
|
FSBM Holdings Bhd
KLSE:FSBM
|
MY |
|
Sandesh Ltd
NSE:SANDESH
|
IN |
|
A
|
Aryaman Financial Services Ltd
BSE:530245
|
IN |
|
C
|
Crazy Sports Group Ltd
HKEX:82
|
CN |
|
B
|
Brickell Biotech Inc
F:VCC2
|
US |
|
H
|
Hunan Gold Corp Ltd
SZSE:002155
|
CN |
|
G
|
Guangdong Anda Automation Solutions Co Ltd
SSE:688125
|
CN |
|
Lululemon Athletica Inc
NASDAQ:LULU
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
Lotus Pharmaceutical Co Ltd
stock under the Base Case scenario is
hidden
TWD.
Compared to the current market price of 216 TWD,
Lotus Pharmaceutical Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Lotus Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Lotus Pharmaceutical Co Ltd Competitors
Lotus Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
56.8B TWD | 2.8 | 12 | 13.7 | 17.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
875.9B USD | 13.4 | 42.4 | 28.6 | 30.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
580.2B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.7 | 11.6 | 13.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232B GBP | 5.2 | 30 | 16.6 | 23.4 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD | 4.5 | 16 | 10 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF | 5.1 | 20.7 | 12.8 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | 105.4 | -83.6 | 386.8 | 970 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.2 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
158.2B USD | 2.5 | 19.9 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
119.4B USD | 2.4 | 16.5 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
